Torren Management, LLC Care Dx, Inc. Transaction History
Torren Management, LLC
- $196 Billion
- Q4 2025
A detailed history of Torren Management, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Torren Management, LLC holds 251 shares of CDNA stock, worth $4,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
251Holding current value
$4,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
199Shares Held
54.3MCall Options Held
150KPut Options Held
57.6K-
Black Rock Inc. New York, NY5.29MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$54.6 Million0.0% of portfolio
-
Bamco Inc New York, NY3.16MShares$50.3 Million0.13% of portfolio
-
State Street Corp Boston, MA2.57MShares$40.9 Million0.0% of portfolio
-
Ophir Asset Management Pty LTD2.2MShares$35 Million4.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $852M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...